NIAGEN BIOSCIENCE, INC. Repayments of Other Debt
NIAGEN BIOSCIENCE, INC. (NAGE) reported Repayments of Other Debt of $281.09 thousand for the 12-month period ending 2016-12-31, per its 10-K filed 2017-03-16.
Discontinued › Cash Flow › Financing Activities
us-gaap:RepaymentsOfOtherDebt · last filed 2017-03-16
- NIAGEN BIOSCIENCE, INC. repayments of other debt for the quarter ending 2016-12-31 was $0.00.
- NIAGEN BIOSCIENCE, INC. repayments of other debt for the quarter ending 2016-10-01 was $0.00.
- NIAGEN BIOSCIENCE, INC. repayments of other debt for fiscal 2016 was $281.09K.
- NIAGEN BIOSCIENCE, INC. repayments of other debt for fiscal 2016 was $0.00.
- NIAGEN BIOSCIENCE, INC. repayments of other debt for fiscal 2015 was $0.00.
| Period end | Repayments of Other Debt 3 month | Repayments of Other Debt 6 month | Repayments of Other Debt 9 month | Repayments of Other Debt 12 month |
|---|---|---|---|---|
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | $0.00 derived: sum of 2 quarters · filed 2017-03-16 | $281.09K 10-K · filed 2017-03-16 | |
| 2016-10-01 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 | $281.09K 10-Q · filed 2016-11-10 | ||
| 2016-07-02 | $281.09K 10-Q · filed 2016-11-10 | |||
| 2016-01-02 | $0.00 10-K · filed 2017-03-16 | |||
| 2015-10-03 | $0.00 10-Q · filed 2016-11-10 | |||
| 2015-01-03 | $0.00 10-K · filed 2017-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |